Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $14.2 Million - $22.7 Million
-183,300 Reduced 96.88%
5,900 $647,000
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $10.1 Million - $14.2 Million
171,300 Added 956.98%
189,200 $15.2 Million
Q1 2024

May 15, 2024

SELL
$51.07 - $68.26 $1.27 Million - $1.69 Million
-24,800 Reduced 58.08%
17,900 $1.11 Million
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $405,880 - $568,597
-7,300 Reduced 14.6%
42,700 $2.65 Million
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $4.12 Million - $4.98 Million
50,000 New
50,000 $4.2 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.26B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.